Project
Illumina Body Map 2
Navigation
Downloads
Results for GFI1B
Z-value: 1.52
Motif logo
Transcription factors associated with GFI1B
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
GFI1B
|
ENSG00000165702.8 | growth factor independent 1B transcriptional repressor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GFI1B | hg19_v2_chr9_+_135854091_135854159 | -0.64 | 8.9e-05 | Click! |
Activity profile of GFI1B motif
Sorted Z-values of GFI1B motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr10_+_119184702 | 5.40 |
ENST00000549104.1
|
CTA-109P11.4
|
CTA-109P11.4 |
| chr3_-_149688971 | 4.89 |
ENST00000498307.1
ENST00000489155.1 |
PFN2
|
profilin 2 |
| chr18_-_24445729 | 4.76 |
ENST00000383168.4
|
AQP4
|
aquaporin 4 |
| chr14_-_80677970 | 4.39 |
ENST00000438257.4
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr5_+_36608422 | 4.32 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr3_+_149689066 | 3.70 |
ENST00000593416.1
|
AC117395.1
|
LOC646903 protein; Uncharacterized protein |
| chr17_+_70117153 | 3.59 |
ENST00000245479.2
|
SOX9
|
SRY (sex determining region Y)-box 9 |
| chr11_+_27076764 | 3.46 |
ENST00000525090.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr4_-_176828307 | 3.46 |
ENST00000513365.1
ENST00000513667.1 ENST00000503563.1 |
GPM6A
|
glycoprotein M6A |
| chr10_+_60936921 | 3.02 |
ENST00000373878.3
|
PHYHIPL
|
phytanoyl-CoA 2-hydroxylase interacting protein-like |
| chr14_-_80677815 | 2.99 |
ENST00000557125.1
ENST00000555750.1 |
DIO2
|
deiodinase, iodothyronine, type II |
| chr5_-_96478466 | 2.87 |
ENST00000274382.4
|
LIX1
|
Lix1 homolog (chicken) |
| chr5_-_142077569 | 2.81 |
ENST00000407758.1
ENST00000441680.2 ENST00000419524.2 |
FGF1
|
fibroblast growth factor 1 (acidic) |
| chr5_-_125930877 | 2.81 |
ENST00000510111.2
ENST00000509270.1 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
| chr5_+_36608280 | 2.73 |
ENST00000513646.1
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr1_+_220701740 | 2.63 |
ENST00000366917.4
|
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
| chr7_+_107110488 | 2.59 |
ENST00000304402.4
|
GPR22
|
G protein-coupled receptor 22 |
| chr1_+_220701456 | 2.56 |
ENST00000366918.4
ENST00000402574.1 |
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
| chr5_-_137475071 | 2.56 |
ENST00000265191.2
|
NME5
|
NME/NM23 family member 5 |
| chr3_-_149688655 | 2.48 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
| chr8_+_133931648 | 2.45 |
ENST00000519178.1
ENST00000542445.1 |
TG
|
thyroglobulin |
| chr1_+_162602244 | 2.44 |
ENST00000367922.3
ENST00000367921.3 |
DDR2
|
discoidin domain receptor tyrosine kinase 2 |
| chr4_-_186696561 | 2.40 |
ENST00000445115.1
ENST00000451701.1 ENST00000457247.1 ENST00000435480.1 ENST00000425679.1 ENST00000457934.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr7_+_79765071 | 2.38 |
ENST00000457358.2
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
| chr6_+_123100620 | 2.30 |
ENST00000368444.3
|
FABP7
|
fatty acid binding protein 7, brain |
| chr5_-_125930929 | 2.28 |
ENST00000553117.1
ENST00000447989.2 ENST00000409134.3 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
| chr13_+_113623509 | 2.24 |
ENST00000535094.2
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
| chr15_-_27184664 | 2.21 |
ENST00000541819.2
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chr4_+_154125565 | 2.21 |
ENST00000338700.5
|
TRIM2
|
tripartite motif containing 2 |
| chr6_-_56707943 | 2.18 |
ENST00000370769.4
ENST00000421834.2 ENST00000312431.6 ENST00000361203.3 ENST00000523817.1 |
DST
|
dystonin |
| chr2_+_1418154 | 2.16 |
ENST00000423320.1
ENST00000382198.1 |
TPO
|
thyroid peroxidase |
| chr1_-_230513367 | 2.13 |
ENST00000321327.2
ENST00000525115.1 |
PGBD5
|
piggyBac transposable element derived 5 |
| chr13_+_76413852 | 2.12 |
ENST00000533809.2
|
LMO7
|
LIM domain 7 |
| chr3_-_149688896 | 2.08 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
| chr14_-_80678512 | 2.08 |
ENST00000553968.1
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr11_-_26743546 | 2.03 |
ENST00000280467.6
ENST00000396005.3 |
SLC5A12
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 |
| chr4_+_41362796 | 1.99 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr5_+_140261703 | 1.98 |
ENST00000409494.1
ENST00000289272.2 |
PCDHA13
|
protocadherin alpha 13 |
| chr14_-_53417732 | 1.96 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
| chr19_+_18726786 | 1.96 |
ENST00000594709.1
|
TMEM59L
|
transmembrane protein 59-like |
| chr19_-_55660561 | 1.94 |
ENST00000587758.1
ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr9_+_12693336 | 1.89 |
ENST00000381137.2
ENST00000388918.5 |
TYRP1
|
tyrosinase-related protein 1 |
| chr3_-_179691866 | 1.85 |
ENST00000464614.1
ENST00000476138.1 ENST00000463761.1 |
PEX5L
|
peroxisomal biogenesis factor 5-like |
| chr19_-_35417716 | 1.83 |
ENST00000604333.1
|
CTC-523E23.8
|
CTC-523E23.8 |
| chr6_-_56708459 | 1.81 |
ENST00000370788.2
|
DST
|
dystonin |
| chr15_-_29745003 | 1.81 |
ENST00000560082.1
|
FAM189A1
|
family with sequence similarity 189, member A1 |
| chr19_-_44124019 | 1.77 |
ENST00000300811.3
|
ZNF428
|
zinc finger protein 428 |
| chr3_+_35681728 | 1.77 |
ENST00000421492.1
ENST00000458225.1 ENST00000337271.5 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr12_-_28124903 | 1.76 |
ENST00000395872.1
ENST00000354417.3 ENST00000201015.4 |
PTHLH
|
parathyroid hormone-like hormone |
| chr12_-_82153087 | 1.75 |
ENST00000547623.1
ENST00000549396.1 |
PPFIA2
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
| chr11_+_62009653 | 1.75 |
ENST00000244926.3
|
SCGB1D2
|
secretoglobin, family 1D, member 2 |
| chr4_+_76995855 | 1.75 |
ENST00000355810.4
ENST00000349321.3 |
ART3
|
ADP-ribosyltransferase 3 |
| chr13_-_67802549 | 1.74 |
ENST00000328454.5
ENST00000377865.2 |
PCDH9
|
protocadherin 9 |
| chr21_-_22175450 | 1.70 |
ENST00000435279.2
|
LINC00320
|
long intergenic non-protein coding RNA 320 |
| chr19_+_3933085 | 1.69 |
ENST00000168977.2
ENST00000599576.1 |
NMRK2
|
nicotinamide riboside kinase 2 |
| chr1_+_226736446 | 1.68 |
ENST00000366788.3
ENST00000366789.4 |
C1orf95
|
chromosome 1 open reading frame 95 |
| chr12_+_48513009 | 1.67 |
ENST00000359794.5
ENST00000551339.1 ENST00000395233.2 ENST00000548345.1 |
PFKM
|
phosphofructokinase, muscle |
| chr8_+_11291429 | 1.66 |
ENST00000533578.1
|
C8orf12
|
chromosome 8 open reading frame 12 |
| chr6_+_12290586 | 1.66 |
ENST00000379375.5
|
EDN1
|
endothelin 1 |
| chr12_+_48513570 | 1.65 |
ENST00000551804.1
|
PFKM
|
phosphofructokinase, muscle |
| chr5_-_96478457 | 1.64 |
ENST00000512378.1
|
LIX1
|
Lix1 homolog (chicken) |
| chr4_-_186697044 | 1.63 |
ENST00000437304.2
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr12_+_124155652 | 1.62 |
ENST00000426174.2
ENST00000303372.5 |
TCTN2
|
tectonic family member 2 |
| chr6_+_46620676 | 1.60 |
ENST00000371347.5
ENST00000411689.2 |
SLC25A27
|
solute carrier family 25, member 27 |
| chr15_+_71228826 | 1.59 |
ENST00000558456.1
ENST00000560158.2 ENST00000558808.1 ENST00000559806.1 ENST00000559069.1 |
LRRC49
|
leucine rich repeat containing 49 |
| chr4_-_186732892 | 1.57 |
ENST00000451958.1
ENST00000439914.1 ENST00000428330.1 ENST00000429056.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr16_+_7560114 | 1.57 |
ENST00000570626.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chrX_+_84499081 | 1.51 |
ENST00000276123.3
|
ZNF711
|
zinc finger protein 711 |
| chr18_+_77905894 | 1.51 |
ENST00000589574.1
ENST00000588226.1 ENST00000585422.1 |
AC139100.2
|
Uncharacterized protein |
| chr9_-_73736511 | 1.50 |
ENST00000377110.3
ENST00000377111.2 |
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3 |
| chr2_+_166326157 | 1.50 |
ENST00000421875.1
ENST00000314499.7 ENST00000409664.1 |
CSRNP3
|
cysteine-serine-rich nuclear protein 3 |
| chr5_+_57878859 | 1.50 |
ENST00000282878.4
|
RAB3C
|
RAB3C, member RAS oncogene family |
| chr3_+_173116225 | 1.50 |
ENST00000457714.1
|
NLGN1
|
neuroligin 1 |
| chr4_+_48807155 | 1.48 |
ENST00000504654.1
|
OCIAD1
|
OCIA domain containing 1 |
| chr3_+_159481791 | 1.47 |
ENST00000460298.1
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
| chr7_-_14029515 | 1.47 |
ENST00000430479.1
ENST00000405218.2 ENST00000343495.5 |
ETV1
|
ets variant 1 |
| chr14_-_93214988 | 1.47 |
ENST00000557434.1
ENST00000393218.2 ENST00000334869.4 |
LGMN
|
legumain |
| chr21_-_22175341 | 1.46 |
ENST00000416768.1
ENST00000452561.1 ENST00000419299.1 ENST00000437238.1 |
LINC00320
|
long intergenic non-protein coding RNA 320 |
| chr1_+_204839959 | 1.45 |
ENST00000404076.1
|
NFASC
|
neurofascin |
| chr6_-_123958141 | 1.44 |
ENST00000334268.4
|
TRDN
|
triadin |
| chr14_-_93214915 | 1.44 |
ENST00000553918.1
ENST00000555699.1 ENST00000553802.1 ENST00000554397.1 ENST00000554919.1 ENST00000554080.1 ENST00000553371.1 |
LGMN
|
legumain |
| chr19_-_44123734 | 1.44 |
ENST00000598676.1
|
ZNF428
|
zinc finger protein 428 |
| chrX_+_84498989 | 1.43 |
ENST00000395402.1
|
ZNF711
|
zinc finger protein 711 |
| chr1_+_202091980 | 1.43 |
ENST00000367282.5
|
GPR37L1
|
G protein-coupled receptor 37 like 1 |
| chr15_+_48051920 | 1.43 |
ENST00000559196.1
|
SEMA6D
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
| chr4_-_186696636 | 1.42 |
ENST00000444771.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr12_+_117176090 | 1.42 |
ENST00000257575.4
ENST00000407967.3 ENST00000392549.2 |
RNFT2
|
ring finger protein, transmembrane 2 |
| chrX_+_84499038 | 1.41 |
ENST00000373165.3
|
ZNF711
|
zinc finger protein 711 |
| chr16_-_75301886 | 1.40 |
ENST00000393422.2
|
BCAR1
|
breast cancer anti-estrogen resistance 1 |
| chr7_-_108097144 | 1.39 |
ENST00000418239.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr18_+_11857439 | 1.39 |
ENST00000602628.1
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
| chr3_+_121311966 | 1.39 |
ENST00000338040.4
|
FBXO40
|
F-box protein 40 |
| chr5_-_124080203 | 1.37 |
ENST00000504926.1
|
ZNF608
|
zinc finger protein 608 |
| chr1_+_210406121 | 1.37 |
ENST00000367012.3
|
SERTAD4
|
SERTA domain containing 4 |
| chr12_+_117176113 | 1.36 |
ENST00000319176.7
|
RNFT2
|
ring finger protein, transmembrane 2 |
| chr10_+_24498060 | 1.36 |
ENST00000376454.3
ENST00000376452.3 |
KIAA1217
|
KIAA1217 |
| chr2_+_105050794 | 1.35 |
ENST00000429464.1
ENST00000414442.1 ENST00000447380.1 |
AC013402.2
|
long intergenic non-protein coding RNA 1102 |
| chr6_+_46620705 | 1.35 |
ENST00000452689.2
|
SLC25A27
|
solute carrier family 25, member 27 |
| chr2_-_77749474 | 1.35 |
ENST00000409093.1
ENST00000409088.3 |
LRRTM4
|
leucine rich repeat transmembrane neuronal 4 |
| chr1_+_176432298 | 1.34 |
ENST00000367661.3
ENST00000367662.3 |
PAPPA2
|
pappalysin 2 |
| chr1_+_15272271 | 1.34 |
ENST00000400797.3
|
KAZN
|
kazrin, periplakin interacting protein |
| chr1_+_162601774 | 1.32 |
ENST00000415555.1
|
DDR2
|
discoidin domain receptor tyrosine kinase 2 |
| chr2_-_77749446 | 1.32 |
ENST00000409911.1
|
LRRTM4
|
leucine rich repeat transmembrane neuronal 4 |
| chr7_-_108096765 | 1.31 |
ENST00000379024.4
ENST00000351718.4 |
NRCAM
|
neuronal cell adhesion molecule |
| chr20_+_58179582 | 1.30 |
ENST00000371015.1
ENST00000395639.4 |
PHACTR3
|
phosphatase and actin regulator 3 |
| chr15_-_83378638 | 1.29 |
ENST00000261722.3
|
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit |
| chr17_+_46131843 | 1.29 |
ENST00000577411.1
|
NFE2L1
|
nuclear factor, erythroid 2-like 1 |
| chr12_-_118406028 | 1.28 |
ENST00000425217.1
|
KSR2
|
kinase suppressor of ras 2 |
| chrX_-_71933888 | 1.28 |
ENST00000373542.4
ENST00000339490.3 ENST00000541944.1 ENST00000373539.3 ENST00000373545.3 |
PHKA1
|
phosphorylase kinase, alpha 1 (muscle) |
| chr1_+_164528866 | 1.28 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
| chr2_+_86116396 | 1.26 |
ENST00000455121.3
|
AC105053.4
|
AC105053.4 |
| chr15_+_48413169 | 1.26 |
ENST00000341459.3
ENST00000482911.2 |
SLC24A5
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 5 |
| chr15_+_48413211 | 1.25 |
ENST00000449382.2
|
SLC24A5
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 5 |
| chr6_-_123957942 | 1.25 |
ENST00000398178.3
|
TRDN
|
triadin |
| chr6_-_123958051 | 1.25 |
ENST00000546248.1
|
TRDN
|
triadin |
| chr7_-_108096822 | 1.24 |
ENST00000379028.3
ENST00000413765.2 ENST00000379022.4 |
NRCAM
|
neuronal cell adhesion molecule |
| chr18_-_30050395 | 1.24 |
ENST00000269209.6
ENST00000399218.4 |
GAREM
|
GRB2 associated, regulator of MAPK1 |
| chr4_-_186696425 | 1.23 |
ENST00000430503.1
ENST00000319454.6 ENST00000450341.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr4_-_186696515 | 1.22 |
ENST00000456596.1
ENST00000414724.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr14_+_29236269 | 1.22 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
| chr18_+_56532053 | 1.22 |
ENST00000592452.1
|
ZNF532
|
zinc finger protein 532 |
| chr6_+_146348782 | 1.21 |
ENST00000361719.2
ENST00000392299.2 |
GRM1
|
glutamate receptor, metabotropic 1 |
| chr2_+_158733088 | 1.18 |
ENST00000605860.1
|
UPP2
|
uridine phosphorylase 2 |
| chr3_-_100551141 | 1.18 |
ENST00000478235.1
ENST00000471901.1 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
| chr1_+_202385953 | 1.17 |
ENST00000466968.1
|
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
| chr7_-_37382360 | 1.17 |
ENST00000455119.1
|
ELMO1
|
engulfment and cell motility 1 |
| chr6_-_123958111 | 1.16 |
ENST00000542443.1
|
TRDN
|
triadin |
| chr1_-_49242553 | 1.16 |
ENST00000371833.3
|
BEND5
|
BEN domain containing 5 |
| chr8_+_75736761 | 1.15 |
ENST00000260113.2
|
PI15
|
peptidase inhibitor 15 |
| chr18_+_56532100 | 1.15 |
ENST00000588456.1
ENST00000589481.1 ENST00000591049.1 |
ZNF532
|
zinc finger protein 532 |
| chr12_+_72667203 | 1.14 |
ENST00000547300.1
|
TRHDE
|
thyrotropin-releasing hormone degrading enzyme |
| chr7_-_142630820 | 1.14 |
ENST00000442623.1
ENST00000265310.1 |
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5 |
| chr10_+_52152766 | 1.14 |
ENST00000596442.1
|
AC069547.2
|
Uncharacterized protein |
| chr22_+_38864041 | 1.13 |
ENST00000216014.4
ENST00000409006.3 |
KDELR3
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
| chr4_-_176733377 | 1.13 |
ENST00000505375.1
|
GPM6A
|
glycoprotein M6A |
| chr21_+_35014706 | 1.12 |
ENST00000399353.1
ENST00000444491.1 ENST00000381318.3 |
ITSN1
|
intersectin 1 (SH3 domain protein) |
| chr1_+_45792541 | 1.12 |
ENST00000334815.3
|
HPDL
|
4-hydroxyphenylpyruvate dioxygenase-like |
| chr1_-_19615744 | 1.12 |
ENST00000361640.4
|
AKR7A3
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
| chr7_-_86595190 | 1.11 |
ENST00000398276.2
ENST00000416314.1 ENST00000425689.1 |
KIAA1324L
|
KIAA1324-like |
| chr1_+_156611960 | 1.09 |
ENST00000361588.5
|
BCAN
|
brevican |
| chr3_+_119814070 | 1.09 |
ENST00000469070.1
|
RP11-18H7.1
|
RP11-18H7.1 |
| chr2_+_176987088 | 1.08 |
ENST00000249499.6
|
HOXD9
|
homeobox D9 |
| chr5_+_140529630 | 1.08 |
ENST00000543635.1
|
PCDHB6
|
protocadherin beta 6 |
| chr12_-_59314246 | 1.07 |
ENST00000320743.3
|
LRIG3
|
leucine-rich repeats and immunoglobulin-like domains 3 |
| chr3_+_184055240 | 1.06 |
ENST00000383847.2
|
FAM131A
|
family with sequence similarity 131, member A |
| chr11_+_119056178 | 1.06 |
ENST00000525131.1
ENST00000531114.1 ENST00000355547.5 ENST00000322712.4 |
PDZD3
|
PDZ domain containing 3 |
| chr11_-_40315640 | 1.06 |
ENST00000278198.2
|
LRRC4C
|
leucine rich repeat containing 4C |
| chr1_-_190443931 | 1.05 |
ENST00000445957.2
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
| chr4_-_186733119 | 1.04 |
ENST00000419063.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr11_+_5618029 | 1.03 |
ENST00000515022.1
ENST00000506134.1 |
TRIM6
|
tripartite motif containing 6 |
| chr3_-_49466686 | 1.03 |
ENST00000273598.3
ENST00000436744.2 |
NICN1
|
nicolin 1 |
| chr2_+_162272605 | 1.03 |
ENST00000389554.3
|
TBR1
|
T-box, brain, 1 |
| chr10_+_124221036 | 1.03 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
| chr15_+_32933866 | 1.01 |
ENST00000300175.4
ENST00000413748.2 ENST00000494364.1 ENST00000497208.1 |
SCG5
|
secretogranin V (7B2 protein) |
| chr4_-_100575781 | 1.01 |
ENST00000511828.1
|
RP11-766F14.2
|
Protein LOC285556 |
| chr13_+_98795664 | 1.00 |
ENST00000376581.5
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
| chr1_+_164528616 | 1.00 |
ENST00000340699.3
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
| chr10_+_71211212 | 1.00 |
ENST00000373290.2
|
TSPAN15
|
tetraspanin 15 |
| chr17_-_79895154 | 0.99 |
ENST00000405481.4
ENST00000585215.1 ENST00000577624.1 ENST00000403172.4 |
PYCR1
|
pyrroline-5-carboxylate reductase 1 |
| chr6_-_93433538 | 0.99 |
ENST00000404689.2
|
RP11-127B16.1
|
RP11-127B16.1 |
| chr3_-_158450231 | 0.98 |
ENST00000479756.1
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
| chr4_-_104640973 | 0.98 |
ENST00000304883.2
|
TACR3
|
tachykinin receptor 3 |
| chr18_-_35145728 | 0.98 |
ENST00000361795.5
ENST00000603232.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
| chr19_-_51141196 | 0.97 |
ENST00000338916.4
|
SYT3
|
synaptotagmin III |
| chr10_+_45455207 | 0.97 |
ENST00000334940.6
ENST00000374417.2 ENST00000340258.5 ENST00000427758.1 |
RASSF4
|
Ras association (RalGDS/AF-6) domain family member 4 |
| chr12_+_32638897 | 0.96 |
ENST00000531134.1
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4 |
| chr7_+_55086794 | 0.96 |
ENST00000275493.2
ENST00000442591.1 |
EGFR
|
epidermal growth factor receptor |
| chr2_+_35056422 | 0.96 |
ENST00000592523.1
ENST00000588944.1 ENST00000585391.1 ENST00000591221.1 ENST00000586769.1 ENST00000588650.1 |
AC012593.1
|
AC012593.1 |
| chr17_-_57604227 | 0.96 |
ENST00000584262.1
|
RP11-567L7.6
|
RP11-567L7.6 |
| chr19_+_2867325 | 0.96 |
ENST00000307635.2
ENST00000586426.1 |
ZNF556
|
zinc finger protein 556 |
| chr9_-_14180778 | 0.95 |
ENST00000380924.1
ENST00000543693.1 |
NFIB
|
nuclear factor I/B |
| chr19_+_3880581 | 0.95 |
ENST00000450849.2
ENST00000301260.6 ENST00000398448.3 |
ATCAY
|
ataxia, cerebellar, Cayman type |
| chr17_-_37764128 | 0.94 |
ENST00000302584.4
|
NEUROD2
|
neuronal differentiation 2 |
| chr20_+_36974759 | 0.94 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
| chr8_+_62200509 | 0.94 |
ENST00000519846.1
ENST00000518592.1 ENST00000325897.4 |
CLVS1
|
clavesin 1 |
| chr11_-_33774944 | 0.94 |
ENST00000532057.1
ENST00000531080.1 |
FBXO3
|
F-box protein 3 |
| chr6_-_116601044 | 0.93 |
ENST00000368608.3
|
TSPYL1
|
TSPY-like 1 |
| chr6_+_146348810 | 0.91 |
ENST00000492807.2
|
GRM1
|
glutamate receptor, metabotropic 1 |
| chr17_+_46131912 | 0.91 |
ENST00000584634.1
ENST00000580050.1 |
NFE2L1
|
nuclear factor, erythroid 2-like 1 |
| chr10_-_49813090 | 0.90 |
ENST00000249601.4
|
ARHGAP22
|
Rho GTPase activating protein 22 |
| chr5_+_3596168 | 0.90 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
| chr17_-_79895097 | 0.89 |
ENST00000402252.2
ENST00000583564.1 ENST00000585244.1 ENST00000337943.5 ENST00000579698.1 |
PYCR1
|
pyrroline-5-carboxylate reductase 1 |
| chr2_+_11752379 | 0.89 |
ENST00000396123.1
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
| chr5_+_15500280 | 0.88 |
ENST00000504595.1
|
FBXL7
|
F-box and leucine-rich repeat protein 7 |
| chr11_+_101785727 | 0.88 |
ENST00000263468.8
|
KIAA1377
|
KIAA1377 |
| chr12_-_21910775 | 0.87 |
ENST00000539782.1
|
LDHB
|
lactate dehydrogenase B |
| chr5_-_87974254 | 0.87 |
ENST00000506014.1
ENST00000502301.1 ENST00000513026.1 |
LINC00461
|
long intergenic non-protein coding RNA 461 |
| chr6_+_26225354 | 0.87 |
ENST00000360408.1
|
HIST1H3E
|
histone cluster 1, H3e |
| chr19_-_10687907 | 0.87 |
ENST00000589348.1
|
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
| chr15_+_69857515 | 0.86 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
| chr17_-_57604200 | 0.86 |
ENST00000577478.1
|
RP11-567L7.6
|
RP11-567L7.6 |
| chr17_-_50236039 | 0.85 |
ENST00000451037.2
|
CA10
|
carbonic anhydrase X |
| chr6_+_90192974 | 0.85 |
ENST00000520458.1
|
ANKRD6
|
ankyrin repeat domain 6 |
| chr3_-_165555200 | 0.85 |
ENST00000479451.1
ENST00000540653.1 ENST00000488954.1 ENST00000264381.3 |
BCHE
|
butyrylcholinesterase |
| chr7_-_100808394 | 0.84 |
ENST00000445482.2
|
VGF
|
VGF nerve growth factor inducible |
| chr14_-_103434869 | 0.84 |
ENST00000559043.1
|
CDC42BPB
|
CDC42 binding protein kinase beta (DMPK-like) |
| chr12_+_109273806 | 0.84 |
ENST00000228476.3
ENST00000547768.1 |
DAO
|
D-amino-acid oxidase |
| chr1_+_10290822 | 0.83 |
ENST00000377083.1
|
KIF1B
|
kinesin family member 1B |
| chr12_-_28125638 | 0.82 |
ENST00000545234.1
|
PTHLH
|
parathyroid hormone-like hormone |
| chr22_-_21360736 | 0.82 |
ENST00000547793.2
|
AC002472.1
|
Uncharacterized protein |
Network of associatons between targets according to the STRING database.
First level regulatory network of GFI1B
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 5.1 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 1.3 | 5.1 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 1.2 | 3.6 | GO:0072034 | primary prostatic bud elongation(GO:0060516) bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) renal vesicle induction(GO:0072034) |
| 1.0 | 2.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.6 | 7.0 | GO:0070779 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.6 | 1.9 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.6 | 9.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.6 | 2.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.6 | 3.3 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.6 | 1.7 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.5 | 9.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.4 | 1.7 | GO:0060584 | nitric oxide transport(GO:0030185) negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.4 | 1.5 | GO:0097115 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.4 | 1.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.4 | 1.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.3 | 1.0 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.3 | 0.9 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.3 | 1.8 | GO:0021764 | amygdala development(GO:0021764) |
| 0.3 | 0.8 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.3 | 0.8 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.3 | 5.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.3 | 4.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.3 | 1.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.3 | 3.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.3 | 1.0 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.3 | 1.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.2 | 0.7 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.2 | 1.2 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.2 | 4.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.2 | 1.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 | 0.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
| 0.2 | 0.7 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.2 | 0.9 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 3.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 | 1.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 | 1.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.2 | 2.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.2 | 0.8 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.2 | 10.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 1.4 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.2 | 0.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.2 | 2.2 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 | 2.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.2 | 2.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
| 0.2 | 2.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 1.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.2 | 5.5 | GO:0006833 | water transport(GO:0006833) |
| 0.2 | 1.4 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.2 | 1.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.2 | 0.6 | GO:2000410 | tolerance induction dependent upon immune response(GO:0002461) regulation of thymocyte migration(GO:2000410) |
| 0.1 | 2.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 0.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.6 | GO:0090290 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 | 0.7 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 | 5.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 1.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 | 1.7 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 1.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 1.0 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 | 0.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.1 | 0.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.1 | 0.4 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.1 | 0.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.1 | 0.7 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 0.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 | 0.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 1.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) hyperosmotic salinity response(GO:0042538) |
| 0.1 | 2.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.1 | 0.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.4 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 0.9 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 2.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 2.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.1 | 4.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.1 | 0.7 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.1 | 0.6 | GO:0036343 | psychomotor behavior(GO:0036343) |
| 0.1 | 0.2 | GO:0006433 | glutamyl-tRNA aminoacylation(GO:0006424) prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 | 0.4 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 2.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 0.6 | GO:0072554 | blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.1 | 0.4 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
| 0.1 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.1 | 0.2 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) |
| 0.1 | 0.7 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 0.3 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.1 | 0.5 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 | 4.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.1 | 0.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 2.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.1 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.1 | 1.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 | 0.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.1 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.2 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 | 1.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 | 1.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
| 0.1 | 1.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 1.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.1 | 4.8 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.0 | 0.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.0 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.0 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 | 1.3 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 | 0.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.0 | 0.8 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 | 1.0 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 1.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.0 | 1.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.0 | 0.3 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.0 | 0.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.0 | 1.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 1.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 1.4 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.0 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.0 | 0.1 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.0 | 0.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.3 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.0 | 0.9 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.0 | 2.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 1.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.0 | 6.0 | GO:0030010 | establishment of cell polarity(GO:0030010) |
| 0.0 | 1.6 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.0 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.0 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.0 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.0 | 0.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.0 | 0.7 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.0 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.0 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 4.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 1.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 2.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 1.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.0 | 0.1 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.0 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.0 | 0.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.0 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 0.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 1.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.2 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 1.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 1.9 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.8 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.3 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.0 | 1.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 2.3 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.0 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.0 | 1.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 1.3 | GO:0060349 | bone morphogenesis(GO:0060349) |
| 0.0 | 0.3 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 4.0 | GO:0031673 | H zone(GO:0031673) |
| 0.6 | 1.7 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.5 | 2.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.4 | 2.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.4 | 3.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.4 | 5.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.3 | 1.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.2 | 0.6 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.2 | 4.6 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.6 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.1 | 3.0 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 5.4 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 1.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 1.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 1.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 1.2 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 1.9 | GO:0005861 | troponin complex(GO:0005861) |
| 0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 1.5 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 1.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 9.5 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 1.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.2 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 2.2 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.1 | 4.0 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 0.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.1 | 1.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.1 | 1.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 1.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 4.0 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 2.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 11.3 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 1.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 0.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.0 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 1.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.0 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 1.6 | GO:0042641 | actomyosin(GO:0042641) |
| 0.0 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 4.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.0 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.0 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.8 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.0 | 3.1 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 1.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 13.0 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 3.1 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 1.0 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 1.5 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 2.0 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.0 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.6 | GO:0030120 | vesicle coat(GO:0030120) |
| 0.0 | 4.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 3.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 3.7 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 5.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 8.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 3.3 | GO:0098793 | presynapse(GO:0098793) |
| 0.0 | 0.6 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 9.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.9 | 3.5 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.7 | 7.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.5 | 1.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.4 | 1.7 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.4 | 1.5 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.3 | 3.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 1.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 1.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.3 | 2.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.3 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.3 | 2.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.3 | 3.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 4.8 | GO:0015250 | water channel activity(GO:0015250) |
| 0.3 | 1.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 3.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 10.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 0.7 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.2 | 1.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.2 | 2.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.2 | 0.6 | GO:0032181 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.2 | 0.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.2 | 1.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 5.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.2 | 4.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 1.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.2 | 1.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 0.8 | GO:0033265 | acetylcholinesterase activity(GO:0003990) choline binding(GO:0033265) |
| 0.2 | 1.4 | GO:0042835 | BRE binding(GO:0042835) |
| 0.2 | 0.5 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 2.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 0.8 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.1 | 2.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.1 | 9.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 5.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.1 | 1.9 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.1 | 0.4 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.1 | 2.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 1.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 1.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.1 | 0.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.1 | 2.9 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 4.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.7 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.1 | 0.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 1.2 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 2.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 0.2 | GO:0004827 | glutamate-tRNA ligase activity(GO:0004818) proline-tRNA ligase activity(GO:0004827) |
| 0.1 | 0.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.1 | 0.3 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) sulfonylurea receptor binding(GO:0017098) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.1 | 0.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.1 | 0.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.1 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.5 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 1.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 0.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.1 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.0 | 1.5 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 7.8 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.0 | 1.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 1.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.5 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.0 | 1.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.0 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.0 | 1.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 2.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.0 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.0 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.0 | 2.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 3.7 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.0 | 0.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.0 | 5.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 1.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.0 | 1.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 4.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 2.6 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 0.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.0 | 1.8 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.0 | 5.4 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.0 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.0 | 0.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 1.4 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.1 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
| 0.0 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.0 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 0.1 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 1.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 1.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 1.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 8.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 2.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 3.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 4.4 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 3.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 1.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 2.6 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 1.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 2.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 11.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.3 | 4.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 2.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 9.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 3.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 3.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 2.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 1.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 4.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 2.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 1.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.1 | 2.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 1.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.0 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 1.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.0 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.0 | 0.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 1.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 7.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 1.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.0 | 1.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 7.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 1.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.0 | 1.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 1.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 0.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 2.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |